HK1004920A1 - Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound - Google Patents

Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Info

Publication number
HK1004920A1
HK1004920A1 HK98104021A HK98104021A HK1004920A1 HK 1004920 A1 HK1004920 A1 HK 1004920A1 HK 98104021 A HK98104021 A HK 98104021A HK 98104021 A HK98104021 A HK 98104021A HK 1004920 A1 HK1004920 A1 HK 1004920A1
Authority
HK
Hong Kong
Prior art keywords
methods
stress
diagnostic kits
toxic
compound
Prior art date
Application number
HK98104021A
Other languages
English (en)
Inventor
Spencer B Farr
Marque D Todd
Original Assignee
Harvard College
Xenometrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21734317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1004920(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College, Xenometrix Inc filed Critical Harvard College
Publication of HK1004920A1 publication Critical patent/HK1004920A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
HK98104021A 1993-01-21 1998-05-08 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound HK1004920A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US889693A 1993-01-21 1993-01-21
PCT/US1994/000583 WO1994017208A1 (en) 1993-01-21 1994-01-21 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Publications (1)

Publication Number Publication Date
HK1004920A1 true HK1004920A1 (en) 1998-12-11

Family

ID=21734317

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104021A HK1004920A1 (en) 1993-01-21 1998-05-08 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Country Status (12)

Country Link
US (3) US5811231A (xx)
EP (1) EP0680517B2 (xx)
JP (1) JP3509100B2 (xx)
AT (1) ATE160178T1 (xx)
AU (1) AU692434B2 (xx)
CA (1) CA2154265C (xx)
DE (1) DE69406772T3 (xx)
DK (1) DK0680517T4 (xx)
ES (1) ES2111289T5 (xx)
GR (1) GR3026129T3 (xx)
HK (1) HK1004920A1 (xx)
WO (1) WO1994017208A1 (xx)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2111289T5 (es) * 1993-01-21 2005-07-16 President And Fellows Of Harvard College Metodos y kits de diagnostico que emplean promotores de estres en mamiferos para determinar la toxicidad de un compuesto.
ATE400651T1 (de) * 1993-09-10 2008-07-15 Univ Columbia Verwendung von grünem fluoreszenzprotein
GB9420735D0 (en) * 1994-10-14 1994-11-30 Karobio Ab Reporter cell line
GB9424497D0 (en) * 1994-12-05 1995-01-25 Karobio Ab Reporter cell line
US6387651B1 (en) 1995-04-12 2002-05-14 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US6326140B1 (en) 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
GB9526509D0 (en) * 1995-12-23 1996-02-28 Univ Dundee Gene control
US6110671A (en) * 1996-04-04 2000-08-29 The United States Of America As Represented By The Secretary Of The Army Method of measuring tumor suppressor gene p53
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
EP0972074A1 (en) * 1997-02-28 2000-01-19 E.I. Du Pont De Nemours & Company Incorporated A method for identifying the site of action of xenobiotic chemicals
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
GB9706414D0 (en) * 1997-03-27 1997-05-14 Univ Manchester Detection of DNA damage
US7031843B1 (en) * 1997-09-23 2006-04-18 Gene Logic Inc. Computer methods and systems for displaying information relating to gene expression data
EP0969100A4 (en) * 1997-09-29 2005-03-16 Hsp Res Inst Inc METHOD FOR THE INVESTIGATION OF EXPRESSION-INDUCTIVE REGULATORS OF HEAT SHOCK PROTEINS
EP1032663A1 (en) * 1997-11-20 2000-09-06 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
CA2321931A1 (en) * 1998-03-06 1999-09-10 E.I. Du Pont De Nemours And Company Methods for identifying polycationic, peptide-like compounds with antibacterial activity
US5965352A (en) * 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
AU750975B2 (en) * 1998-05-12 2002-08-01 Rosetta Inpharmatics, Inc. Quantitative methods, systems and apparatuses for gene expression analysis
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
US6501003B1 (en) 1998-07-08 2002-12-31 Wisconsin Alumni Research Foundation Transgentic mouse expressing green fluorescent protein in glial cells
US20030105044A1 (en) * 2001-10-17 2003-06-05 Isis Pharmaceuticals Inc. Antisense modulation of matrix metalloproteinase 1 expression
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US6468476B1 (en) * 1998-10-27 2002-10-22 Rosetta Inpharmatics, Inc. Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6950752B1 (en) 1998-10-27 2005-09-27 Rosetta Inpharmatics Llc Methods for removing artifact from biological profiles
US6453241B1 (en) * 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6370478B1 (en) 1998-12-28 2002-04-09 Rosetta Inpharmatics, Inc. Methods for drug interaction prediction using biological response profiles
US6222093B1 (en) * 1998-12-28 2001-04-24 Rosetta Inpharmatics, Inc. Methods for determining therapeutic index from gene expression profiles
AU4186600A (en) * 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
DE60030796T2 (de) 1999-04-14 2007-09-13 Sumitomo Chemical Co., Ltd. Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren
WO2000063683A1 (en) 1999-04-20 2000-10-26 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6673554B1 (en) * 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20080183395A1 (en) * 1999-06-28 2008-07-31 Michael Bevilacqua Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
US20040225449A1 (en) * 1999-06-28 2004-11-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
US20050060101A1 (en) * 1999-06-28 2005-03-17 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US7049132B1 (en) * 1999-06-28 2006-05-23 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
EP1194527A4 (en) * 1999-06-28 2004-04-14 Univ Southern California INDUCTION OF THERAPEUTIC AGENT IN RESPONSE TO STRESS AND METHODS THEREOF
US20060115826A1 (en) * 1999-06-28 2006-06-01 Michael Bevilacqua Gene expression profiling for identification monitoring and treatment of multiple sclerosis
US6931396B1 (en) 1999-06-29 2005-08-16 Gene Logic Inc. Biological data processing
US20020087511A1 (en) * 1999-09-02 2002-07-04 Johnson Peter C. Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
US6727100B1 (en) * 1999-10-21 2004-04-27 4Sc Ag Method of identifying candidate molecules
GB2355791B (en) * 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
EP1130086A1 (en) * 2000-02-18 2001-09-05 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genetically engineered keratinocytes and toxicity assay using said keratinocytes
US20040115627A1 (en) * 2000-04-12 2004-06-17 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism
US6696239B1 (en) 2000-04-20 2004-02-24 Biolog, Inc. Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials
JP2004523201A (ja) * 2000-05-16 2004-08-05 ザ チルドレンズ マーシー ホスピタル シングルコピーゲノムのハイブリダイゼーションプローブおよびその作製方法
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
US7020561B1 (en) 2000-05-23 2006-03-28 Gene Logic, Inc. Methods and systems for efficient comparison, identification, processing, and importing of gene expression data
US20030171876A1 (en) * 2002-03-05 2003-09-11 Victor Markowitz System and method for managing gene expression data
US6902882B2 (en) 2000-05-23 2005-06-07 Kerong Gu Methods of monitoring production of gene products and uses thereof
US20030009295A1 (en) * 2001-03-14 2003-01-09 Victor Markowitz System and method for retrieving and using gene expression data from multiple sources
US20020012905A1 (en) * 2000-06-14 2002-01-31 Snodgrass H. Ralph Toxicity typing using liver stem cells
WO2002006834A2 (en) * 2000-07-19 2002-01-24 Pointilliste, Inc. Nested sorting and high throughput screening
WO2002008453A2 (en) * 2000-07-21 2002-01-31 Phase-1 Molecular Toxicology Canine toxicity genes
US7613571B2 (en) * 2000-07-28 2009-11-03 Doyle Michael D Method and system for the multidimensional morphological reconstruction of genome expression activity
US7590493B2 (en) 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
WO2002010453A2 (en) * 2000-07-31 2002-02-07 Gene Logic, Inc. Molecular toxicology modeling
CA2327581A1 (en) * 2000-12-27 2002-06-27 Yves Blais Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules
US20020192671A1 (en) * 2001-01-23 2002-12-19 Castle Arthur L. Method and system for predicting the biological activity, including toxicology and toxicity, of substances
WO2002063032A1 (en) * 2001-02-05 2002-08-15 Shen Quan Pan Methods and kits for identifying scavengers of reactive oxygen species (ros)
CA2438832A1 (en) * 2001-02-23 2002-09-06 Elan Pharmaceuticals, Inc. Transgenic knockouts of bace-1
EP1383911A4 (en) * 2001-04-02 2004-12-15 Cytoprint Inc METHOD AND APPARATUS FOR DISCOVERING, IDENTIFYING AND COMPARING BIOLOGICAL ACTIVITY MECHANISMS
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
CA2447357A1 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
US20070054269A1 (en) * 2001-07-10 2007-03-08 Mendrick Donna L Molecular cardiotoxicology modeling
JP2005517400A (ja) * 2001-07-10 2005-06-16 ジーン ロジック インコーポレイテッド 心臓毒分子毒性モデリング
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
US7251642B1 (en) 2001-08-06 2007-07-31 Gene Logic Inc. Analysis engine and work space manager for use with gene expression data
AU2002323286A1 (en) * 2001-08-16 2003-03-03 Phase-1 Molecular Toxicology, Inc. Human toxicologically relevant genes and arrays
WO2003018839A1 (en) * 2001-08-23 2003-03-06 University College Dublin, National University Of Ireland, Dublin Identification of a common promoter module in disease associated genes
JP2003079365A (ja) 2001-09-07 2003-03-18 Kanegafuchi Chem Ind Co Ltd 環境有害化学物質の高感度検出法
US7842498B2 (en) 2001-11-08 2010-11-30 Bio-Rad Laboratories, Inc. Hydrophobic surface chip
JP5236856B2 (ja) * 2001-11-09 2013-07-17 ライフ テクノロジーズ コーポレーション 遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定
EP1474504A2 (en) * 2002-01-24 2004-11-10 Pointilliste, Inc. Use of collections of binding sites for sample profiling and other applications
JP2005535285A (ja) * 2002-01-31 2005-11-24 ジーン ロジック インコーポレイテッド 分子肝毒性モデリング
US7704272B2 (en) 2002-01-31 2010-04-27 University Of Rochester Method for introducing an ultraviolet light activated viral vector into the spinal column
US7524327B2 (en) 2002-01-31 2009-04-28 University Of Rochester Light activated gene transduction using long wavelength ultraviolet light for cell targeted gene delivery
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
MXPA04011424A (es) * 2002-05-17 2005-02-17 Baylor College Medicine Patrones diferenciales de expresion genetica que predicen la quimioresistencia y quimiosensibilidad a docetaxel.
ITTO20020729A1 (it) * 2002-08-14 2004-02-15 Consorzio Interuniversitario Per Le Biotecnologie Cellule di mammifero non umano geneticamente modificate, procedimento per la loro produzione e utilizzo in test di tossicita'.
WO2004042019A2 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
US20040241748A1 (en) * 2003-02-10 2004-12-02 Dana Ault-Riche Self-assembling arrays and uses thereof
US7853406B2 (en) 2003-06-13 2010-12-14 Entelos, Inc. Predictive toxicology for biological systems
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
EP1654536A4 (en) * 2003-08-07 2008-07-30 Ocimum Biosolutions Inc MODELING OF HEPATOCYTE PRIMARY TOXICITY IN THE RAT
WO2005045426A2 (en) * 2003-11-10 2005-05-19 Aic Gene expression profiling of hazardous compounds and corresponding database clustering algorithm
US20080281526A1 (en) * 2004-03-22 2008-11-13 Diggans James C Methods For Molecular Toxicology Modeling
WO2005100989A2 (en) * 2004-04-07 2005-10-27 Gene Logic, Inc. Hepatotoxicity molecular models
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
US7232808B2 (en) * 2004-08-02 2007-06-19 University Of Iowa Research Foundation Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD)
US7646450B2 (en) * 2005-12-29 2010-01-12 Lg Display Co., Ltd. Light emitting diode array, method of manufacturing the same, backlight assembly having the same, and LCD having the same
US20070218456A1 (en) * 2006-02-08 2007-09-20 Invitrogen Corporation Cellular assays for signaling receptors
US20100015128A1 (en) * 2006-10-03 2010-01-21 University Of Southern California GRP78 as a Predictor of Responsiveness to Therapeutic Agents
CA2715080C (en) 2007-09-28 2021-09-28 Intrexon Corporation Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
BRPI0920679A2 (pt) 2008-10-08 2022-05-17 Intrexon Corp Células construídas expressando múltiplos imunomoduladores e usos das mesmas
EP2199794A1 (en) 2008-12-17 2010-06-23 Universiteit Maastricht Method for the identification of carcinogenic compounds
KR20130142186A (ko) * 2011-04-08 2013-12-27 앤섬 바이오사이언시즈 프라이빗 리미티드 진핵세포에서 유전독성 물질의 고효율 스크리닝을 위한 인비트로 방법
CN103930566B (zh) * 2011-09-08 2018-01-26 埃塔格尼公司 用于测定水中生物污染物的系统和方法
WO2019070704A1 (en) * 2017-10-02 2019-04-11 Georgia Tech Research Corporation METHODS AND COMPOSITIONS FOR ENGINEERING SYNTHESIS BIOLOGICAL SWITCHES FOR REMOTE CONTROL OF BIOLOGICAL ACTIVITY
AU2019218260B2 (en) 2018-02-09 2022-01-06 W. L. Gore & Associates, Inc. Implantable access chamber and associated methods of use
KR102382748B1 (ko) * 2020-07-28 2022-04-05 가톨릭대학교 산학협력단 Egr1 프로모터 영역을 포함하는 재조합 벡터 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533584B1 (fr) * 1982-09-28 1986-03-21 Pasteur Institut Procede de detection du pouvoir mutagene de substances, susceptibles d'induire la deterioration d'adn cellulaires, mettant en jeu la production d'une reponse sos
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US4997757A (en) * 1987-12-23 1991-03-05 Genebiomed, Inc. Process for detecting potential carcinogens
NL8801826A (nl) * 1988-07-19 1990-02-16 Tno Werkwijze voor het detecteren van mutaties in markergenen.
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
GB8905394D0 (en) * 1989-03-09 1989-04-19 Delta Biotechnology Ltd Detection of certain molecules
US5149634A (en) * 1989-04-14 1992-09-22 The University Of Maryland Bioassay for environmental quality
JPH04506902A (ja) * 1989-07-18 1992-12-03 オンコジーン・サイエンス・インコーポレイテッド 遺伝子発現の転写変調方法及び遺伝子発現モジュレーターとして作用できる化学物質の検出方法
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
HUT61810A (en) † 1989-07-18 1993-03-01 Oncogene Science Inc Apparatus, process and laboratory plates for laboratory tests
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
HUT66827A (en) * 1990-09-24 1995-01-30 Brent Screening assays
CA2098849C (en) * 1990-12-20 2007-07-10 Ralph R. Weichselbaum Control of gene expression by ionizing radiation
NL9100567A (nl) * 1991-04-02 1992-11-02 Ingeny Bv Werkwijze voor het detecteren van mutaties, transgeen zoogdier, transgene zoogdiercel, en werkwijze voor het onderzoeken van stoffen of omstandigheden op mutagene eigenschappen.
EP0516443A1 (en) * 1991-05-31 1992-12-02 Eli Lilly And Company Vectors and methods for assaying the regulation of apolipoprotein ai synthesis
JP3456703B2 (ja) * 1992-07-06 2003-10-14 プレジデント アンド フェローズ オブ ハーバード カレッジ リポーター遺伝子に融合した細菌のストレスプロモーターを用いる毒性を測定するための方法および診断用キット
ES2111289T5 (es) * 1993-01-21 2005-07-16 President And Fellows Of Harvard College Metodos y kits de diagnostico que emplean promotores de estres en mamiferos para determinar la toxicidad de un compuesto.

Also Published As

Publication number Publication date
WO1994017208A1 (en) 1994-08-04
US5811231A (en) 1998-09-22
ES2111289T5 (es) 2005-07-16
AU6124394A (en) 1994-08-15
EP0680517B2 (en) 2005-01-19
DE69406772T3 (de) 2005-11-17
GR3026129T3 (en) 1998-05-29
US20030219714A1 (en) 2003-11-27
DE69406772D1 (de) 1997-12-18
JP3509100B2 (ja) 2004-03-22
DK0680517T3 (da) 1998-07-27
EP0680517A1 (en) 1995-11-08
CA2154265A1 (en) 1994-08-04
JPH09503121A (ja) 1997-03-31
DE69406772T2 (de) 1998-03-12
AU692434B2 (en) 1998-06-11
EP0680517B1 (en) 1997-11-12
US20030027127A1 (en) 2003-02-06
DK0680517T4 (da) 2005-05-02
CA2154265C (en) 2011-01-04
ATE160178T1 (de) 1997-11-15
ES2111289T3 (es) 1998-03-01

Similar Documents

Publication Publication Date Title
GR3026129T3 (en) Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound.
EA199800566A1 (ru) Аденовирусный вектор (варианты), способ его получения, применение, репликационно-компетентное не содержащее аденовирус потомство, способ повышения размножения в комплементирующей клеточной линии аденовирусного вектора, способ генетической модификации клетки, композиция, клетка-хозяин, способ тестирования токсичности аденовирусного вектора, способ тестирования экспрессии чужеродного гена или гена-пассажира аденовирусного вектора
DE69638162D1 (de) Bindegewebs wachstumsfaktor (ctgf)
EA200000325A1 (ru) Способ доставки генов в антиген-презентирующие клетки кожи
CA2139667A1 (en) Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
BR0303011A (pt) Painel de diagnóstico de câncer
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
FI950409A0 (fi) Yhdistelmä soluja, DNA-rakenteita, vektoreita ja menetelmiä fytaattia hajoittavien entsyymien ilmentämiseksi toivotuissa suhteissa
CA2298681A1 (en) Methods and compositions for overcoming resistance to biologic and chemotherapy
DE69322166D1 (de) Prüfung auf ein vielfache resistenz gegen antibiotika verursachendes operon
EA199900507A1 (ru) Способы профилактики отторжения трансплантата при трансплантации и продуцирования универсальной клетки-хозяина для генной терапии
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
HU9300397D0 (en) Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR FIXING TAU AND MAP2c PROTEINS
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
WO1998010085A3 (en) Gene therapy for congestive heart failure
DE69428278T2 (de) Leukozytadhaesiontest
BR9712128A (pt) Métodos e composições para lipidização de moléculas hidrofìlicas
DK0782630T3 (da) Polycystisk nyresygdomsgen
DE69837808D1 (de) pRb2/p130 PEPTIDINHIBITOREN DER cdk2 KINASEAKTIVITÄT
WO2000018907A3 (de) Antisense-sequenzen für die hemmung der expression des adhäsionsmoleküls icam-1
AU6363486A (en) Promoter arrangement for streptomycetes vectors

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050121